Uncovering Institutional Buying In Acrivon Therapeutics Inc (NASDAQ: ACRV)
Currently, there are 31.23M common shares owned by the public and among those 21.74M shares have been available to trade. The company’s stock has a 5-day price change of -9.39% and -69.91% over the past three months. ACRV shares are trading -72.76% year to date (YTD), with the 12-month market performance down to -83.30% lower. […]
